Published in Cancer Res on December 07, 2012
The role of semaphorins and their receptors in vascular development and cancer. Exp Cell Res (2013) 1.07
Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk. J Clin Invest (2014) 0.92
Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeability. Microcirculation (2014) 0.85
Distinct roles of DKK1 and DKK2 in tumor angiogenesis. Angiogenesis (2013) 0.82
Neuropilin-1 expression is induced on tolerant self-reactive CD8+ T cells but is dispensable for the tolerant phenotype. PLoS One (2014) 0.81
Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity. Oncogene (2015) 0.79
Depletion of CD11c(+) cells in the CD11c.DTR model drives expansion of unique CD64(+) Ly6C(+) monocytes that are poised to release TNF-α. Eur J Immunol (2015) 0.78
VEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin-1+ monocyte/TGF-β1 paracrine axis. EMBO Mol Med (2015) 0.78
The Role of Semaphorin 3A in Bone Remodeling. Front Cell Neurosci (2017) 0.75
The role of the semaphorins in cancer. Cell Adh Migr (2016) 0.75
Laser Therapy Inhibits Tumor Growth in Mice by Promoting Immune Surveillance and Vessel Normalization. EBioMedicine (2016) 0.75
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition. EMBO Mol Med (2016) 0.75
VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans. Cancer Gene Ther (2016) 0.75
The Role of Angiogenesis in Cancer Treatment. Biomedicines (2017) 0.75
Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell (2007) 5.09
Functional screening identifies miRNAs inducing cardiac regeneration. Nature (2012) 4.39
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell (2004) 4.38
Modification of kidney barrier function by the urokinase receptor. Nat Med (2007) 4.01
Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet (2008) 3.94
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature (2003) 3.42
Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET. Clin Cancer Res (2013) 2.61
Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell (2010) 2.26
Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells. PLoS Biol (2009) 2.16
Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J Biol Chem (2003) 2.09
Effect of class IV laser therapy on chemotherapy-induced oral mucositis: a clinical and experimental study. Am J Pathol (2013) 2.09
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell (2003) 2.07
Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J (2003) 2.02
Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol (2002) 1.97
Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther (2004) 1.96
A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell (2011) 1.95
Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ Res (2006) 1.93
The TRIM family protein KAP1 inhibits HIV-1 integration. Cell Host Microbe (2011) 1.79
Modeling the early stages of vascular network assembly. EMBO J (2003) 1.78
Integrins and angiogenesis: a sticky business. Exp Cell Res (2005) 1.69
Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer (2003) 1.69
Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood (2006) 1.65
Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood (2005) 1.65
Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression. Cardiovasc Res (2009) 1.63
Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J Cell Biol (2005) 1.61
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat Med (2002) 1.59
Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension. J Hypertens (2005) 1.56
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J Clin Invest (2009) 1.56
Modeling human tumor angiogenesis in a three-dimensional culture system. Blood (2013) 1.55
Microsurgical arterovenous loops and biological templates: a novel in vivo chamber for tissue engineering. Microsurgery (2007) 1.54
Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem (2002) 1.52
Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol Ther (2003) 1.52
Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum Gene Ther (2010) 1.51
The synaptic proteins β-neurexin and neuroligin synergize with extracellular matrix-binding vascular endothelial growth factor a during zebrafish vascular development. Arterioscler Thromb Vasc Biol (2012) 1.50
Transcription-dependent gene looping of the HIV-1 provirus is dictated by recognition of pre-mRNA processing signals. Mol Cell (2008) 1.50
Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury. Crit Care Med (2003) 1.50
The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication. J Virol (2007) 1.46
Modular structure of the human lamin B2 replicator. Mol Cell Biol (2004) 1.46
Enhanced athletic performance on multisite AAV-IGF1 gene transfer coincides with massive modification of the muscle proteome. Hum Gene Ther (2012) 1.44
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer. Cancer Res (2005) 1.44
MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation (2013) 1.42
Diffusion-limited phase separation in eukaryotic chemotaxis. Proc Natl Acad Sci U S A (2005) 1.41
Notch1 signaling stimulates proliferation of immature cardiomyocytes. J Cell Biol (2008) 1.39
Acetylation of HIV-1 integrase by p300 regulates viral integration. EMBO J (2005) 1.39
Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. FASEB J (2009) 1.39
Vascular endothelial growth factor induces brain erythropoietin expression? Funct Neurol (2006) 1.38
Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression. Clin Cancer Res (2005) 1.37
Acetylation by GCN5 regulates CDC6 phosphorylation in the S phase of the cell cycle. Nat Struct Mol Biol (2009) 1.36
Virus-mediated gene delivery for human gene therapy. J Control Release (2012) 1.35
Essential role of PDK1 in regulating endothelial cell migration. J Cell Biol (2007) 1.35
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice. Circulation (2006) 1.31
Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell (2004) 1.28
Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. EMBO J (2003) 1.26
In vivo study of HIV-1 Tat arginine-rich motif unveils its transport properties. Mol Ther (2007) 1.25
AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs. FASEB J (2008) 1.24
Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther (2003) 1.22